Search Results - "Seavers, Lisa C. A."
-
1
Identification of N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design
Published in Journal of medicinal chemistry (28-08-2008)“…The application of fragment-based screening techniques to cyclin dependent kinase 2 (CDK2) identified multiple (>30) efficient, synthetically tractable small…”
Get full text
Journal Article -
2
Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors
Published in Journal of medicinal chemistry (23-02-2006)“…The screening of fragments is an alternative approach to high-throughput screening for the identification of leads for therapeutic targets. Fragment hits have…”
Get full text
Journal Article -
3
Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B
Published in Bioorganic & medicinal chemistry (15-02-2006)“…Novel pyrrolidine-derived isoquinoline-5-sulfonamide inhibitors of PKB were designed, and investigated crystallographically and in cellular assays…”
Get full text
Journal Article -
4
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
Published in Journal of medicinal chemistry (27-01-2005)“…We describe the structure-guided optimization of the molecular fragments 2-amino-3-benzyloxypyridine 1 (IC50 1.3 mM) and 3-(2-(4-pyridyl)ethyl)indole 2 (IC50…”
Get full text
Journal Article -
5
Identification of N -(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1 H -pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design
Published in Journal of medicinal chemistry (01-08-2008)Get full text
Journal Article -
6
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation
Published in Journal of medicinal chemistry (27-01-2005)“…We describe the structure-guided optimization of the molecular fragments 2-amino-3-benzyloxypyridine 1 (IC(50) 1.3 mM) and 3-(2-(4-pyridyl)ethyl)indole 2…”
Get full text
Journal Article